PRISM BioLab Co.,LTD (206A.T)

JPY 244.0

(-4.69%)

Operating Expenses Summary of PRISM BioLab Co.,LTD

  • PRISM BioLab Co.,LTD's latest annual operating expenses in 2023 was 576.81 Million JPY , up 23.21% from previous year.
  • PRISM BioLab Co.,LTD's latest quarterly operating expenses in 2024 Q3 was 266.67 Million JPY , down 0.0% from previous quarter.
  • PRISM BioLab Co.,LTD reported a annual operating expenses of 468.45 Million JPY in annual operating expenses 2022, down 0.0% from previous year.
  • PRISM BioLab Co.,LTD reported a quarterly operating expenses of 577.17 Million JPY for 2023 FY, up 23.21% from previous quarter.
  • PRISM BioLab Co.,LTD reported a quarterly operating expenses of 468.45 Million JPY for 2022 FY, down 0.0% from previous quarter.

Annual Operating Expenses Chart of PRISM BioLab Co.,LTD (2023 - 2022)

Historical Annual Operating Expenses of PRISM BioLab Co.,LTD (2023 - 2022)

Year Operating Expenses Operating Expenses Growth
2023 576.81 Million JPY 23.21%
2022 468.45 Million JPY 0.0%

Peer Operating Expenses Comparison of PRISM BioLab Co.,LTD

Name Operating Expenses Operating Expenses Difference
KOHJIN BIO CO LTD 1.28 Billion JPY 55.093%
GNI Group Ltd. 9.32 Billion JPY 93.813%
Linical Co., Ltd. 2.7 Billion JPY 78.677%
Trans Genic Inc. 2.15 Billion JPY 73.293%
MEDINET Co., Ltd. 1.49 Billion JPY 61.318%
Soiken Holdings Inc. 3.07 Billion JPY 81.218%
Cytori Cell Research Institute, Inc. 1.85 Billion JPY 68.938%
AnGes, Inc. 8.9 Billion JPY 93.521%
OncoTherapy Science, Inc. 943.08 Million JPY 38.837%
Nxera Pharma Co., Ltd. 19.19 Billion JPY 96.994%
Immuno-Biological Laboratories Co., Ltd. 412.99 Million JPY -39.668%
NanoCarrier Co., Ltd. 975.37 Million JPY 40.862%
Carna Biosciences, Inc. 2.56 Billion JPY 77.535%
CanBas Co., Ltd. 278 Million JPY -107.487%
D. Western Therapeutics Institute, Inc. 1.14 Billion JPY 49.47%
RaQualia Pharma Inc. 1.81 Billion JPY 68.271%
Chiome Bioscience Inc. 1.6 Billion JPY 64.034%
Kidswell Bio Corporation 2.37 Billion JPY 75.703%
PeptiDream Inc. 9.68 Billion JPY 94.046%
Oncolys BioPharma Inc. 1.96 Billion JPY 70.58%
Ribomic Inc. 1.1 Billion JPY 47.832%
SanBio Company Limited 4.53 Billion JPY 87.292%
Healios K.K. 3.48 Billion JPY 83.458%
BrightPath Biotherapeutics Co., Ltd. 1.15 Billion JPY 50.048%
Kubota Pharmaceutical Holdings Co., Ltd. 1.33 Billion JPY 56.776%
Delta-Fly Pharma, Inc. 1.4 Billion JPY 58.901%
StemRIM 2.07 Billion JPY 72.215%
CellSource Co., Ltd. 1.96 Billion JPY 70.623%
FunPep Company Limited 313.82 Million JPY -83.804%
Kringle Pharma, Inc. 958.01 Million JPY 39.79%
Stella Pharma Corporation 963.98 Million JPY 40.163%
TMS Co., Ltd. 943.25 Million JPY 38.848%
Noile-Immune Biotech Inc. 1.08 Billion JPY 47.079%
Cuorips Inc. 598.11 Million JPY 3.562%
K Pharma,Inc. 543.94 Million JPY -6.043%
Takara Bio Inc. 23.9 Billion JPY 97.587%
ReproCELL Incorporated 1.51 Billion JPY 61.902%
PhoenixBio Co., Ltd. 1.18 Billion JPY 51.282%
StemCell Institute Inc. 1.16 Billion JPY 50.365%
Japan Tissue Engineering Co., Ltd. 1.52 Billion JPY 62.108%
CellSeed Inc. 804.93 Million JPY 28.34%